Skip to content
TriangleGet started
← Hodgkin Lymphoma

FOR PATIENTS · SOURCE READING

Watchful waiting

Source: Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: February 27, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview / For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:

Watchful waiting is closely monitoring a patient's condition without giving any treatment until signs or symptoms appear or change.

Preserved source evidence · Independent clinical review pending · Not medical advice